Compugen Story

<div class='circular--portrait' style='background:#82ADFD;color: #ffffff;font-size:4em;'>CO</div>
CGEN -- USA Stock  

USD 18.16  0.28  1.57%

As many of us are excited about healthcare space, it is fair to outline Compugen within current market trends. As expected, Compugen is starting to reaffirm its true potential as institutional investors are becoming more and more confident in the future outlook. The company returns are very sensitive to each other to returns on the market. As market twists, the company is expected to follow. Conflicting basic indicators of the company may also entail signs of long-standing losses for Compugen institutional investors. Compugen is scheduled to announce its earnings today. The next earnings report is expected on the 9th of November 2020. The stock is still going through an active upward rally.
Published over a month ago
View all stories for Compugen | View All Stories
Should you purchase Compugen (NASDAQ:CGEN) based on latest technical indicators?
Compugen's average rating is Strong Buy from 7 analysts. Do analysts base this consensus on technical analyses? We know that typical technical analysis utilizes price momentum, patterns, and trends looking at historical prices. It aims to identify signals based on Compugen market sentiment investors' perception of the future value of Compugen. Let us look at a few aspects of Compugen technical analysis.
Using predictive technical analysis, we will analyze different prices and returns patterns and diagnose historical swings to determine the real value of Compugen. In general, we focus on analyzing Compugen stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Compugen's daily price indicators and compare them against related drivers such as momentum indicators and various other types of predictive indicators. Using this methodology combined with a more conventional technical analysis and fundamental analysis, we attempt to find the most accurate representation of Compugen's intrinsic value. In addition to deriving basic predictive indicators for Compugen, we also check how macroeconomic factors affect Compugen price patterns. Please read more on our technical analysis page or use our predictive modules below to complement your research.

How does Compugen Stands against Peers?

Analyzing Compugen competition or peers my help you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Try to analyze the advantages of investing in traded instruments related to Compugen across multiple sectors and thematic ideas. A good competitive analysis can cover a lot of different areas. But what areas to choose depends on who you are. The more exhaustive you are in your analysis, the more effective your competitive analysis will be.
Check out Compugen Competition Details

What do experts say?

Stock analysis is a method for investors and traders to make buying and selling decisions. By studying and evaluating past and current data, investors and traders attempt to gain an edge in the markets by making informed decisions. It is good to see analyst projects for Compugen, but it might be worth checking our own buy vs. sell analysis

Closer look at Compugen Variance

Compugen has current Variance of 44.17. Variance is another measure of security risk that shows the amount of dispersion of equity returns around their mean value. Variance is calculated as the average squared deviations from the mean. Evaluating a set of investment alternatives one can use variance to help determine the volatility when purchasing a specific security. Similar to Standard Deviation, the variance is a measure of how far a set of numbers is spread out around its mean.

Variance is also a measure of stock volatility and can help determine the risk an investor might take on when purchasing a specific security. A relatively big variance indicates that the daily prices or returns are far from the mean and a small variance indicates that they are located around the mean.

Variance 
 = 
SUM(RET DEV)2 
 = 
44.17
SUM = Summation notation
RET DEV = Actual returns deviation over selected period
N = Number of points for the period
Let's now compare Compugen Variance to its closest peers:
CGEN
DNLI
DMPI
DRNA
NK
CGEN44.16964537263746
DNLI15.82
DMPI90.56
DRNA22.14
NK93.54

Will Compugen growth be justifiable after the thrive?

Compugen information ratio is up to 0.0. Compugen is displaying above-average volatility over the selected time horizon. Investors should scrutinize Compugen independently to ensure intended market timing strategies are aligned with expectations about Compugen volatility.

Our Final Takeaway

Whereas some firms under the biotechnology industry are still a bit expensive, Compugen may offer a potential longer-term growth to institutional investors. The inconsistency in the assessment between current Compugen valuation and our trade advice on Compugen is due to the recent market swings and your selection of investing horizon. Please use our equity advice module to run different scenarios to ensure your current risk level and investment horizon are fully reflective of your current investing preferences in regards to Compugen.

About Contributor

This story should be regarded as informational only and should not be considered a solicitation to sell or buy any financial products. Macroaxis does not express any opinion as to the present or future value of any investments referred to in this post. This post may not be reproduced without the consent of Macroaxis LLC. Macroaxis LLC and Achuva Shats do not own shares of Compugen. Please refer to our Terms of Use for any information regarding our disclosure principles.

Would you like to provide feedback on the content of this article?

You can get in touch with us directly or send us a quick note via email to editors@macroaxis.com